In human AML, CD25 is also expressed in LSC, but the components CD132 and CD122 consist the IL-2 receptor with CD25 are lacked, which indicating the signaling signature of CD25 in maintaining and generating leukemia may be different that in CML [13]. This evidence concerns the gene IL2RB and chronic myelogenous leukemia, BCR-ABL1 positive.